ETV7 limits the antiviral and antitumor efficacy of CD8+ T cells by diverting their fate toward exhaustion.
Cheng J, Xiao Y, Peng T, Zhang Z, Qin Y, Wang Y, Shi J, Yan J, Zhao Z, Zheng L, He Z, Wang J, Zhang Z, Li C, Zhu H, Jiang P.
Cheng J, et al. Among authors: zheng l.
Nat Cancer. 2025 Jan 13. doi: 10.1038/s43018-024-00892-0. Online ahead of print.
Nat Cancer. 2025.
PMID: 39805956